Table 3 Pooled prevalence of Multidrug Resistance of E. coli, Klebsiella spp and Staphylococcus spp- based on meta-analysis of human studies with respect to study area
Bacteria mostly reported in studies | Study Area (Region) | Number of studies | Pooled prevalence of AMR (95% CI) | p value |
|---|---|---|---|---|
E. coli | Centre | 6 | 35.9 (24.2–49.6) | 0.25 |
South-West | 3 | 45.6 (35.6–56.0) | 0.82 | |
North-West | 3 | 60.9 (33.0–83.2) | 0.33 | |
West | 3 | 40.9 (28.1–55.0) | 0.61 | |
Klebsiella spp | Centre | 4 | 45.8 (28.3–64.1) | 0.65 |
South-West | 4 | 51.6 (38.5–64.5) | 0.82 | |
North-West | 2 | 52.6 (30.5–73.7) | 0.64 | |
West | 2 | 57.9 (47.7–67.4) | 0.13 | |
Staphylococcus spp | Centre | 5 | 39.2 (23.2–57.8) | 0.45 |
South-West | 2 | 62.2 (18.2–92.4) | 0.20 | |
North-West | 5 | 45.3 (36.2–54.7) | 0.69 | |
West | 4 | 56.6 (32.0–78.4) | 0.45 |